Loading clinical trials...
Loading clinical trials...
Benign hypertrophy of the prostate (BPH) is a disease seen in 20% of men over the age of 50 and in 40% of those over the age of 70. The gold standard in the treatment of BPH is transurethral resection...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Istanbul University
NCT06962085 · TURP(Transurethral Resection of Prostate)
NCT05351489 · Transurethral Resection of Prostate
NCT06753071 · Underactive Bladder, TURP(transurethral Resection of Prostate), and more
NCT03324477 · Transurethral Resection of Prostate Syndrome
NCT06153602 · Transurethral Resection of Prostate
Istanbul University
Istanbul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions